# Major Recall Alert: CIPROFIT 500 (Ciprofloxacin Tablet USP 500mg) Recalled Due to Falsified Product Containing Only 5.7% Ciprofloxacin
In a shocking development, the National Agency for Food and Drug Administration and Control (NAFDAC) has announced the recall of **CIPROFIT 500 (Ciprofloxacin Tablet USP 500mg)** manufactured by Impact Pharmaceutical Ltd. The product has been confirmed to be falsified, containing only **5.7% Ciprofloxacin**, drastically below the acceptable limits of **90-110% potency**, posing significant risks to public health.
## Why This Recall is Important
Ciprofloxacin is an essential antibiotic used to treat various bacterial infections, including respiratory tract infections, urinary tract infections, and skin conditions. When a drug contains only a fraction of the active ingredient, it becomes ineffective in treating infections, which can lead to prolonged illnesses, potential complications, and the development of **antimicrobial resistance (AMR).**
The confirmed **falsified CIPROFIT 500 tablets**, containing far less Ciprofloxacin than required, endanger lives by providing inadequate treatment while allowing bacteria to thrive. This recall emphasizes the need for vigilance when purchasing medications in Nigeria and underscores the importance of regulatory bodies like **NAFDAC** in protecting consumer health.
## Details of the Recall
Here’s what you need to know about the recall:
- **Category**: Nigeria – Falsified Pharmaceutical Products
- **Product**: CIPROFIT 500 (Ciprofloxacin Tablet USP 500mg)
- **Manufacturer**: Impact Pharmaceutical Ltd
- **Issue**: The tablets contain only **5.7% Ciprofloxacin**, which is far below the standard range of **90-110%** for an effective dose.
- **Recall Date Announced**: March 30, 2025
- **Images**: To help consumers identify the product, refer to these [Ciprofit tablet images from NAFDAC](https://nafdac.gov.ng/wp-content/uploads/2025/09/Ciprofit.png) and [Ciprofit packaging images](https://nafdac.gov.ng/wp-content/uploads/2025/09/Ciprofit1.png).
This recall is a stark reminder of the dangers of falsified pharmaceutical products and the need for strict regulation to ensure safe and effective treatments for patients.
## What You Should Do
To protect yourself and those around you, follow these essential safety measures immediately:
- **Stop Using CIPROFIT 500**: If you have this product in your possession, discontinue its use right away.
- **Return Stock to NAFDAC Offices**: Submit any remaining stock of CIPROFIT 500 tablets to the nearest **NAFDAC** office. Locate your nearest office at [NAFDAC Official Website](https://nafdac.gov.ng/).
- **Report Adverse Reactions**: If you have experienced side effects or adverse reactions while using CIPROFIT 500, promptly report these to NAFDAC through:
- Phone: Call NAFDAC’s customer service line
- Email: Send an email to NAFDAC
- Online: Utilize the **NAFDAC E-reporting platforms** available on their website.
Your swift action can make a significant difference in preventing further harm caused by these falsified tablets.
## Stay Safe – Get Instant Recall Alerts
With the rise of falsified and substandard pharmaceutical products, staying informed is key to protecting your health. Download **NAFDAC’s official app** to receive instant alerts about product recalls and updates on pharmaceutical safety in Nigeria. By staying informed, you can help protect yourself, your family, and your community from counterfeit and dangerous medications.
For further details on this recall, visit the official [NAFDAC source](https://nafdac.gov.ng/updated-public-alert-no-030b-2025-sale-of-confirmed-falsified-ciprofit-500/). Stay vigilant, stay safe, and take proactive steps to safeguard your health today!
---
Preventative care begins with awareness – **download the NAFDAC app now** for ongoing alerts and updates to ensure you and your family use only safe, authentic products.